Stay Updated with the Latest Compass Diversified CODI-PA News in Real Time
Find CODI-PA news now at Meyka AI. Stay informed with the latest Compass Diversified stocks updates, including price news, market analysis, and expert insights.
Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback
Robinhood stock closed at $95.77 on August 19, 2026, up 4.63% for the session. Strategy, Coinbase, and Circle all posted stronger gains the same day. The U.S. Treasury’s expanded bond buyback program eased yields and lifted risk appetite across crypto-linked equities. Bitcoin climbed above $68,000, extending gains into $71,600 territory by Thursday morning. Why Robinhood…
Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection
Strides Pharma shares surged 11% to ₹1,055.90 on the BSE on August 20, 2026. The rally followed news that the company’s flagship Bengaluru facility received a USFDA Establishment Inspection Report. That report confirms successful closure of a cGMP inspection conducted in May 2026. Heavy trading volumes accompanied the sharp intraday move. What the USFDA EIR…
Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model
Gaja Alternative IPO’s Grey Market Premium stood at ₹21 as of Thursday, August 20, 2026, 9:45 AM IST. That implies a listing price near ₹181, a 13% premium over the ₹160 upper band. The ₹550 crore issue from Gaja Capital’s asset management arm closes for subscription on August 21. Overall subscription remained modest at 0.30…
Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 19
Stellantis recalls 955,000 vehicles worldwide due to radio software preventing rearview camera display. Fix via over-the-air update starting September. No injuries reported.
Stellantis Recalls 955,000 Vehicles Over Camera Software Flaw on August 18
Stellantis recalls 955,000 Chrysler, Jeep, Dodge and Ram vehicles over rearview camera software glitch. Fix via over-the-air update. No injuries reported.
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review. This marks AstraZeneca’s second major trial halt…
NSE IPO Listings: Molbio Diagnostics, Dhoot Transmission Debut Today; Check GMPs
Two new NSE IPO listings hit the market on Monday, August 17, 2026. Molbio Diagnostics and Dhoot Transmission both made their stock market debuts today. Dhoot Transmission shares surged 37.06% on the NSE, opening at ₹1,193.80. Molbio Diagnostics listed with a smaller but solid 21.44% premium at ₹980. Both companies had commanded strong grey market…
HDFC Mid-Cap Fund Turns ₹10 Lakh Into ₹1.25 Crore in 13 Years
HDFC Mid-Cap Fund delivered ₹1.25 crore returns on a ₹10 lakh investment over 13 years. The fund focuses on mid-cap stocks with at least 65% allocation and carries very high risk.
Technocraft Ventures IPO Subscription Hits 6.98x on Day 3 as NII Demand Leads
Technocraft Ventures IPO closed its subscription window Tuesday, August 11, 2026, at 6.98 times overall. Non-institutional investors drove the strongest demand, pushing this EPC infrastructure issue well past full subscription. The ₹251.88 crore mainboard IPO priced shares between ₹200 and ₹212. Strong grey market activity suggests investors expect a solid listing debut this week. Technocraft…